Chemical Kinetic Strategies for High‐Throughput Screening of Protein Aggregation Modulators. Issue 4 (1st February 2019)

• Record Type: Journal Article
• Authors: Sárkány, Zsuzsa; Rocha, Fernando; Damas, Ana M.; Macedo‐Ribeiro, Sandra; Martins, Pedro M.
• Is Part Of: Chemistry, an Asian journal. Volume 14:Issue 4(2019)
• Page Start: 500
• Page End: 508
• Publication Date: 2019-02-01
• Subjects: amyloid diseases -- drug discovery -- nucleation -- protein aggregation -- soluble oligomers; Chemistry -- Periodicals; 540.5
• DOI: 10.1002/asia.201801703
• Languages: English
• ISSNs: 1861-4728

Abstract

Abstract: Insoluble aggregates staining positive to amyloid dyes are known histological hallmarks of different neurodegenerative disorders and of type II diabetes. Soluble oligomers are smaller assemblies whose formation prior to or concomitant with amyloid deposition has been associated to the processes of disease propagation and cell death. While the pathogenic mechanisms are complex and differ from disease to disease, both types of aggregates are important biological targets subject to intense investigation in academia and industry. Here we review recent advances in the fundamental understanding of protein aggregation that can be used on the development of anti‐amyloid and anti‐oligomerization drugs. Specifically, we pinpoint the chemical kinetic aspects that should be attended during the development of high‐throughput screening assays and in the hit validation phase. The strategies here devised are expected to establish a connection between basic research and pharmaceutical innovation. Abstract : On the road again : A kinetic roadmap is presented for high‐throughput screening of protein aggregation modifiers. We review the different mechanisms of action of known anti‐amyloid and anti‐olgomerization compounds and show how their effect can be identified in reaction progress curves.